Susquehanna International Group, LLP Profound Medical Corp. Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$3.18 - $10.91 $94,865 - $325,467	29,832 New	29,832 $324,000
Q4 2021 Feb 14, 2022	BUY	$10.38 - $15.2 $176,885 - $259,023	17,041 Added 103.56%	33,496 $376,000
Q3 2021 Nov 15, 2021	SELL	$13.6 - $17.88 $90,848 - $119,438	-6,680 Reduced 28.87%	16,455 $241,000
Q1 2021 May 17, 2021	BUY	$19.16 - $28.09 $107,334 - $157,360	5,602 Added 31.95%	23,135 $466,000
Q4 2020 Feb 16, 2021	BUY	$16.4 - $22.9 $287,541 - $401,505	17,533 New	17,533 $360,000

8.93M

1.2K

Ticker PROF
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,851,300
Market Cap $148M
Description
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.